Gemcitabine for the treatment of advanced nonsmall cell lung cancer | OTT | Dove Medical Press · Shell

reader mode source ↗

Skip to main content

Journals
Why Publish With Us?
Editorial Policies
Author Guidelines
Peer Review Guidelines
Collections
Hot topics
Podcasts
Reprints
Submit New Manuscript

About
Contact
Sustainability
Press Center
Testimonials
Favored Author Program
Permissions
Pre-Submission
Reprints
Login

Open access to scientific and medical research

Journals
Why publish with us?
Editorial Policies
Author Information
Peer Review Guidelines
Collections
Hot topics
Latest Articles
Videos
Podcasts

Back to Journals » OncoTargets and Therapy » Volume 2

Contact Us • Privacy Policy • Associations & Partners • Testimonials • Terms & Conditions • Recommend this site • Top

Contact Us • Privacy Policy

© Copyright 2026 • Dove Medical Press Ltd

The opinions expressed in all articles published here are those of the specific author(s), and do not necessarily reflect the views of Dove Medical Press Ltd or any of its employees.

Dove Medical Press is part of Taylor & Francis Group, the Academic Publishing Division of Informa PLC
Copyright 2026 Informa PLC. All rights reserved. This site is owned and operated by Informa PLC ( “Informa”) whose registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36